Target intelligence / Profile preview

F4 fimbria of Escherichia coli (F4 fimbria)

Target
F4 fimbria
Molecular classification
Bacterial adhesin, Fimbria (Pilus), Chaperone-usher pathway fimbria, Lectin-type adhesin, Surface organelle
01

Overview

F4 fimbriae are long, filamentous protein structures expressed on the surface of enterotoxigenic Escherichia coli (ETEC), primarily affecting pigs[1][2][3]. They are assembled through the chaperone-usher pathway, with FaeG as the major subunit responsible for both the structural framework and adhesive properties[1]. F4 fimbriae enable the bacteria to adhere tightly to the glycosphingolipid and glycoprotein receptors on the epithelial cells of the porcine small intestine, facilitating colonization and subsequent delivery of enterotoxins that induce diarrhea[1][3]. Three serological variants exist (F4ab, F4ac, F4ad), each with variant-specific receptor binding patterns determined by the primary sequence of FaeG[1][3]. The carbohydrate binding site is unique among the variants and determines the fimbriae's tropism and host specificity[1]. F4 fimbriae do not directly act as receptors or enzymes themselves, but function as adhesins—a key enabling step in ETEC pathogenesis, and therefore represent viable therapeutic or vaccine targets in veterinary medicine[5][6].

Other names
F4 pilusK88 antigenF4 fimbriaeF4ab/fimbriaF4ac/fimbriaF4ad/fimbria
02

Mechanism of action

Potential therapeutics may act as carbohydrate receptor analogs to block E. coli adhesion[5]. Antibody-mediated neutralization of F4 fimbriae to prevent colonization.

03

Biological functions

Bacterial adhesion to host cellsHost-cell colonizationTissue tropismMediates delivery of bacterial toxins
04

Disease associations

Infection (specifically, diarrheal disease and post-weaning diarrhea in pigs)Veterinary infectious disease
05

Safety considerations

No specific therapeutic safety concerns, but targeting fimbriae may select for resistance or drive antigenic variation.Use in vaccines may require careful antigenic matching due to variant diversity (F4ab, F4ac, F4ad).
06

Interacting drugs

No clinically approved drugs specifically target F4 fimbria; however, research into receptor analogs, anti-adhesion therapies, or antibodies is ongoing[5].
07

Biomarkers

Detection of F4 fimbriae in E. coli isolates as a diagnostic marker for enterotoxigenic strains causing porcine diarrhea.

Beyond the preview

Go deeper on F4 fimbria of Escherichia coli (F4 fimbria).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on F4 fimbria of Escherichia coli (F4 fimbria).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call